Viewing Study NCT02641457


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-01-02 @ 3:37 AM
Study NCT ID: NCT02641457
Status: COMPLETED
Last Update Posted: 2015-12-29
First Post: 2015-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis
Sponsor: Instituto de Olhos de Goiania
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module